Interact to see
Advertisement
Advertisement
BYM vs NUV
BYM vs NUV Comparison Chart in %
Loading...
Show more...
Show more...
View a ticker or compare two or three
VS
VS
BYM vs. NUV commentary
Jul 27, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BYM is a Hold and NUV is a Hold.
SUMMARIES
FUNDAMENTALS
Fundamentals
NUV has more net assets: 1.83B vs. BYM (292M). NUV has a higher annual dividend yield than BYM: NUV (2.068) vs BYM (-0.690). BYM was incepted earlier than NUV: BYM (23 years) vs NUV (38 years). NUV (0.47) has a lower expense ratio than BYM (1.49). BYM has a higher turnover NUV (21.00) vs NUV (21.00).
| BYM | NUV | BYM / NUV | |
| Gain YTD | -0.690 | 2.068 | -33% |
| Net Assets | 292M | 1.83B | 16% |
| Total Expense Ratio | 1.49 | 0.47 | 317% |
| Turnover | 53.00 | 21.00 | 252% |
| Yield | 4.98 | 4.22 | 118% |
| Fund Existence | 23 years | 38 years | - |
TECHNICAL ANALYSIS
Technical Analysis
| BYM | NUV | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 82% | 3 days ago 70% |
| Stochastic ODDS (%) | 3 days ago 76% | 3 days ago 82% |
| Momentum ODDS (%) | 3 days ago 68% | 3 days ago 69% |
| MACD ODDS (%) | 3 days ago 70% | 3 days ago 76% |
| TrendWeek ODDS (%) | 3 days ago 82% | 3 days ago 70% |
| TrendMonth ODDS (%) | 3 days ago 81% | 3 days ago 74% |
| Advances ODDS (%) | 6 days ago 85% | 3 days ago 76% |
| Declines ODDS (%) | 10 days ago 76% | 5 days ago 76% |
| BollingerBands ODDS (%) | 3 days ago 86% | 3 days ago 83% |
| Aroon ODDS (%) | 3 days ago 75% | 3 days ago 70% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Show more...
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ASVIX | 10.10 | 0.06 | +0.60% |
| American Century Small Cap Value Inv | |||
| VITSX | 152.68 | 0.67 | +0.44% |
| Vanguard Total Stock Market Idx I | |||
| GCLLX | 17.21 | 0.06 | +0.35% |
| Goldman Sachs Enhanced U.S. Equity C | |||
| VECRX | 22.33 | 0.07 | +0.31% |
| Virtus KAR Equity Income R6 | |||
| FBTTX | 25.58 | N/A | N/A |
| Fidelity Advisor Biotechnology M | |||